all you really have to compare it to is AGN at a 70 million market cap before GLP and phase 1 studies in 2021, NYR is a more effective treatment with no need of combining it with thrombotics and a single therapy and not a dual therapy which is already proven to work
Current market cap is 22 million with 5 million in cash and 3-4 million in rebates coming after July 1st. Got a significant rerate to go as it was at 40 cents last time without it being proven and this current results exceeded modelling so previous highs will be tested short term
- Forums
- ASX - By Stock
- Nyrada Talks PreClinical Success with 180 Markets
all you really have to compare it to is AGN at a 70 million...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NYR (ASX) to my watchlist
|
|||||
Last
5.2¢ |
Change
-0.005(8.77%) |
Mkt cap ! $9.474M |
Open | High | Low | Value | Volume |
5.3¢ | 5.3¢ | 5.2¢ | $3.717K | 70.31K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 30704 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 27857 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 30704 | 0.052 |
1 | 30000 | 0.051 |
3 | 32000 | 0.050 |
1 | 100000 | 0.044 |
2 | 294464 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 27857 | 2 |
0.057 | 333605 | 4 |
0.058 | 83446 | 1 |
0.061 | 150000 | 1 |
0.065 | 71643 | 2 |
Last trade - 15.09pm 04/09/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |